Authors: Martha Powell, Future Science Group
The US FDA has approved Zemdri (plazomicin) for use in adults with complicated urinary tract infections (cUTIs) caused by certain Enterobacteriaceae. However, it isn’t all good news as the agency has also issued a response for bloodstream infections, noting there isn’t substantial evidence of Zemdri’s effectiveness.
Restricted Content / Members Only
Restricted Content / Members Only